Literature DB >> 22382928

Geographic difference in advanced gastric cancer prevalence and chemotherapy treatment results: could it really be an independent prognostic factor?

Junichi Sakamoto, Koji Oba.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22382928     DOI： 10.1007/s10120-011-0131-4

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN： 1436-3291            Impact factor:   7.370


× No keyword cloud information.
  12 in total

1.  Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan.

Authors:  Masashi Takano; Masafumi Kato; Tomoyuki Yoshikawa; Tomoko Goto; Kenichi Furuya; Yoshihiro Kikuchi
Journal:  Int J Clin Oncol       Date:  2010-02-24       Impact factor: 3.402

2.  Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma.

Authors:  Jaffer A Ajani; Josephine Faust; Kazumasa Ikeda; James C Yao; Hiroshi Anbe; Kelli L Carr; Michele Houghton; Peter Urrea
Journal:  J Clin Oncol       Date:  2005-09-06       Impact factor: 44.544

3.  Distribution of the UGT1A1*28 polymorphism in Caucasian and Asian populations in the US: a genomic analysis of 138 healthy individuals.

Authors:  Jackie Yao Liu; Kevin Qu; Anthony D Sferruzza; Richard A Bender
Journal:  Anticancer Drugs       Date:  2007-07       Impact factor: 2.248

4.  Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States.

Authors:  Ai Kubo; Douglas A Corley
Journal:  Am J Gastroenterol       Date:  2004-04       Impact factor: 10.864

5.  Race and ethnicity correlate with survival in patients with gastric adenocarcinoma.

Authors:  J Kim; C-L Sun; B Mailey; C Prendergast; A Artinyan; S Bhatia; A Pigazzi; J D I Ellenhorn
Journal:  Ann Oncol       Date:  2009-07-21       Impact factor: 32.976

Review 6.  The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal junction adenocarcinoma in Japan.

Authors:  T Koike; S Ohara; Y Inomata; Y Abe; K Iijima; T Shimosegawa
Journal:  Inflammopharmacology       Date:  2007-04       Impact factor: 4.473

7.  Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center.

Authors:  Sharlene Gill; Amil Shah; Nhu Le; E Francis Cook; Eric M Yoshida
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

8.  Potential regional differences for the tolerability profiles of fluoropyrimidines.

Authors:  Daniel G Haller; Jim Cassidy; Stephen J Clarke; David Cunningham; Eric Van Cutsem; Paulo M Hoff; Mace L Rothenberg; Leonard B Saltz; Hans-Joachim Schmoll; Carmen Allegra; Joseph R Bertino; Jean-Yves Douillard; Bengt G Gustavsson; Gerard Milano; Michael O'Connell; Youcef Rustum; Josep Tabernero; Frank Gilberg; Florin Sirzén; Chris Twelves
Journal:  J Clin Oncol       Date:  2008-05-01       Impact factor: 44.544

9.  Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan.

Authors:  Chika Kusano; Takuji Gotoda; Christopher J Khor; Hitoshi Katai; Hoichi Kato; Hirokazu Taniguchi; Tadakazu Shimoda
Journal:  J Gastroenterol Hepatol       Date:  2008-11       Impact factor: 4.029

10.  Geographic difference in safety and efficacy of systemicchemotherapy for advanced gastric or gastroesophagealcarcinoma: a meta-analysis and meta-regression.

Authors:  Chiun Hsu; Ying-Chun Shen; Chia-Chi Cheng; Ann-Lii Cheng; Fu-Chang Hu; Kun-Huei Yeh
Journal:  Gastric Cancer       Date:  2012-05-12       Impact factor: 7.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.